PremiumThe FlyCocrystal Pharma reports Q3 EPS (49c), consensus (57c) Cocrystal Pharma (COCP) Q3 Earnings Cheat Sheet Cocrystal Pharma Advances Antiviral Drug Development PremiumCompany AnnouncementsCocrystal Pharma Engages Investors at Upcoming Conferences Cocrystal Pharma reports Q2 EPS (54c), consensus (48c) COCP Upcoming Earnings Report: What to Expect? PremiumThe FlyCocrystal Pharma reports Q1 EPS (39c) vs (64c) last year Cocrystal Pharma (COCP) Q1 Earnings Cheat Sheet Cocrystal announces completion of enrollment in Phase 2a study of CC-42344